A pilot study of the potential acceptability of vaporised nicotine products for smoking cessation or long-term substitution among smokers

Phase 1

Active, not recruiting

• Conditions: Tobacco Dependence; Mental Health - Addiction; Infection - Acquired immune deficiency syndrome (AIDS / HIV)

• Registration Number: ACTRN12615000829516
• Lead Sponsor: The University of Queensland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-08-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

HIV Positive, currently smoking a minimum of 5 tobacco cigarettes per day, aged 18+, sufficiently proficient in English to provide informed consent and to complete questionnaires, not planning to quit smoking in the next month.

Exclusion Criteria

Exclusion criteria includes, individuals who are;
* pregnant
* breastfeeding
* less than 18 years of age

Individuals who have any of the following will require clearance from a medical practitioner in order to enrol in the study:
* have had a stroke or heart attack or severe angina in the last two weeks
* poorly controlled high blood pressure
* a mental health/psychiatric condition that is being treated with anti-psychotic medication
* overactive thyroid
* adrenal gland tumour
* kidney or liver disease
* a stomach ulcer
* poorly controlled asthma or other throat or airway disease
* insulin dependent diabetes mellitus

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The product selected by the most participants.[End of product trial period (2-5 weeks post recruitment)]